These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37470803)

  • 21. Ginkgo biloba for cognitive impairment and dementia.
    Birks J; Grimley EV; Van Dongen M
    Cochrane Database Syst Rev; 2002; (4):CD003120. PubMed ID: 12519586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Moderate doses of commercial preparations of Ginkgo biloba do not alter markers of liver function but moderate alcohol intake does: A new approach to identify and quantify biomarkers of 'adverse effects' of dietary supplements.
    Lieberman HR; Kellogg MD; Fulgoni VL; Agarwal S
    Regul Toxicol Pharmacol; 2017 Mar; 84():45-53. PubMed ID: 28025058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ginkgo biloba Extract in Vascular Protection: Molecular Mechanisms and Clinical Applications.
    Tian J; Liu Y; Chen K
    Curr Vasc Pharmacol; 2017; 15(6):532-548. PubMed ID: 28707602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ginkgo biloba medicines and food supplements on the Belgian market: a comparative study.
    Saevels J; Corthout J
    J Pharm Belg; 2005; 60(4):129-34. PubMed ID: 16429834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxicology and carcinogenesis studies of Ginkgo biloba extract (CAS No. 90045-36-6) in F344/N rats and B6C3F1/N mice (Gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2013 Mar; (578):1-183. PubMed ID: 23652021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmaceutical quality of different Ginkgo biloba brands.
    Kressmann S; Müller WE; Blume HH
    J Pharm Pharmacol; 2002 May; 54(5):661-9. PubMed ID: 12005361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ginkgo biloba extract in Alzheimer's disease: from action mechanisms to medical practice.
    Shi C; Liu J; Wu F; Yew DT
    Int J Mol Sci; 2010 Jan; 11(1):107-23. PubMed ID: 20162004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Value of Ginkgo biloba in treatment of Alzheimer dementia].
    Loew D
    Wien Med Wochenschr; 2002; 152(15-16):418-22. PubMed ID: 12244890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ginkgolic Acids Confer Potential Anticancer Effects by Targeting Pro- Inflammatory and Oncogenic Signaling Molecules.
    Shanmugam MK; Garg M; Makhija P; Kumar AP; Sharifi-Rad J; Zam W; Bishayee A
    Curr Mol Pharmacol; 2021; 14(5):806-822. PubMed ID: 33573586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders.
    Singh SK; Srivastav S; Castellani RJ; Plascencia-Villa G; Perry G
    Neurotherapeutics; 2019 Jul; 16(3):666-674. PubMed ID: 31376068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An effective identification and quantification method for Ginkgo biloba flavonol glycosides with targeted evaluation of adulterated products.
    Ma YC; Mani A; Cai Y; Thomson J; Ma J; Peudru F; Chen S; Luo M; Zhang J; Chapman RG; Shi ZT
    Phytomedicine; 2016 Apr; 23(4):377-87. PubMed ID: 27002408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of bilobalide, ginkgolide A and B after administration of three different Ginkgo biloba L. preparations in humans.
    Woelkart K; Feizlmayr E; Dittrich P; Beubler E; Pinl F; Suter A; Bauer R
    Phytother Res; 2010 Mar; 24(3):445-50. PubMed ID: 20041430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dosage strength is associated with medication persistence with Ginkgo biloba drug products: a cohort study of ambulatory drug claims data in Germany.
    Czeche S; Schüssel K; Franzmann A; Burkart M; Schulz M
    BMC Complement Altern Med; 2013 Oct; 13():278. PubMed ID: 24156348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An update on drug interactions with the herbal medicine Ginkgo biloba.
    Abad MJ; Bedoya LM; Bermejo P
    Curr Drug Metab; 2010 Feb; 11(2):171-81. PubMed ID: 20359286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ginkgo biloba extract (EGb 761) in Alzheimer's disease: is there any evidence?
    Ramassamy C; Longpré F; Christen Y
    Curr Alzheimer Res; 2007 Jul; 4(3):253-62. PubMed ID: 17627482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The situation of patients with dementia may be rectified by Ginkgo biloba. Results of a health services research study concerning the ability of patients with dementia, quality of life of the nursing family members and total treatment costs].
    Heinen-Kammerer T; Motzkat K; Daniel D; Gertz HJ; Koller M; Lorenz W; Pilartz H; Zimmer B; Habs M; von den Driesch V; Rychlik R
    MMW Fortschr Med; 2005 Oct; 147 Suppl 3():127-33. PubMed ID: 16261949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study.
    Mazza M; Capuano A; Bria P; Mazza S
    Eur J Neurol; 2006 Sep; 13(9):981-5. PubMed ID: 16930364
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.